These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 8895319)

  • 1. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts.
    Conover CA; Khosla S
    Growth Horm IGF Res; 2003 Dec; 13(6):328-35. PubMed ID: 14624766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb.
    Russo VC; Bach LA; Fosang AJ; Baker NL; Werther GA
    Endocrinology; 1997 Nov; 138(11):4858-67. PubMed ID: 9348216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
    Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
    Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
    Yang YW; Yanagishita M; Rechler MM
    Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
    Nam TJ; Busby WH; Rees C; Clemmons DR
    Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
    Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
    J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms.
    Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Lalou C; Binoux M; Monget P
    Endocrinology; 1999 Sep; 140(9):4175-84. PubMed ID: 10465290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.
    Campbell PG; Andress DL
    Am J Physiol; 1997 Nov; 273(5):E1005-13. PubMed ID: 9374688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides.
    Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Monget P
    Biol Reprod; 2000 Aug; 63(2):390-400. PubMed ID: 10906042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase.
    Martin JL; Jambazov S
    Endocrinology; 2006 Sep; 147(9):4400-9. PubMed ID: 16763062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
    Nam TJ; Busby W; Clemmons DR
    Endocrinology; 1997 Jul; 138(7):2972-8. PubMed ID: 9202242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.
    Miyamoto S; Nakamura M; Yano K; Ishii G; Hasebe T; Endoh Y; Sangai T; Maeda H; Shi-Chuang Z; Chiba T; Ochiai A
    Cancer Sci; 2007 May; 98(5):685-91. PubMed ID: 17359288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.